AKTS
#2212
Aktis Oncology, Inc. - Common stock
25.1 7 USD
-0.02%
Sector: Technology
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.56%
Monthly Change
+11.37%
6 month change
+19.52%
Year Change
-6.78%
Previous Close
25.5 7
Open
25.8 2
Low
25.1 4
High
25.8 4
Volume
568
Financials
- Market Capitalization 1.39 B
- Employee 79
- Founded 2020
- CEO N/A
- Website www.aktisoncology.com
- Headquarter Delaware, United States
- FIGI BBG00ZQS8KZ1
- Industry Communication Equipment
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1848 |  DGII Digi International Inc. - Common Stock | 67.63 USD | +2.11% | -2.59% | -2.86% | +104.82% | 2.55 B USD | ||
| 2198 |  HLIT Harmonic Inc. - Common Stock | 13.67 USD | 0.00% | +1.79% | -11.86% | +30.44% | 1.48 B USD | ||
| 2416 |  ITRN Ituran Location and Control Ltd. - Ordinary Shares | 55.28 USD | -0.90% | +0.36% | -18.16% | +44.30% | 1.10 B USD | ||
| 2456 |  ADTN ADTRAN Holdings, Inc. - Common Stock | 12.60 USD | +1.37% | +0.48% | -19.39% | +23.89% | 1.02 B USD |
Frequently asked questions about Aktis Oncology, Inc. - Common stock
What is the Aktis Oncology, Inc. - Common stock stock price today?
The current price of Aktis Oncology, Inc. - Common stock (AKTS) is 25.17. Over the past 24 hours, the stock has changed by -1.56%. Follow the AKTS chart for real-time price dynamics.
What is the stock ticker of Aktis Oncology, Inc. - Common stock?
Aktis Oncology, Inc. - Common stock trades under the ticker AKTS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aktis Oncology, Inc. - Common stock stock going up?
AKTS has changed by -8.74% over the last week, +11.37% over the last month, and -6.78% over the last year. Review the chart to see whether the current move is part of a broader trend.
How many employees does Aktis Oncology, Inc. - Common stock have?
As of the latest available data, Aktis Oncology, Inc. - Common stock has 79 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aktis Oncology, Inc. - Common stock EBITDA?
Aktis Oncology, Inc. - Common stock EBITDA is -22.05 M, and its EBITDA margin is -683.42%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aktis Oncology, Inc. - Common stock stock?
You can buy Aktis Oncology, Inc. - Common stock (AKTS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aktis Oncology, Inc. - Common stock stock?
Investing in Aktis Oncology, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKTS chart and related analysis on metatrader.com as part of your research.